Impact of polymorphisms in microRNA biogenesis genes on colon cancer risk and microRNA expression levels: A population based, case-control study

BMC Medical Genomics

Volumn 9, Issue 1, 2016, Pages

  Mullany, Lila E ^a   Herrick, Jennifer S ^a   Wolff, Roger K ^a   Buas, Matthew F ^b   Slattery, Martha L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Biogenesis; Cancer; Colon; MiRNA; Risk; SNP

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; MESSENGER RNA; MICRORNA;

ADULT; AGED; ARTICLE; BIOGENESIS; BMP2 GENE; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DGCR8 GENE; DOWN REGULATION; GEMIN4 GENE; GENE EXPRESSION; GENETIC RISK; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; MAPKAP2 GENE; ONCOGENE; PRIORITY JOURNAL; PRKRA GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; BIOSYNTHESIS; COLON TUMOR; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; METABOLISM;

CASE-CONTROL STUDIES; COLONIC NEOPLASMS; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER;

EID: 85007595784     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/s12920-016-0181-x     Document Type: Article

References (48)

1. Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006): 350-5.
2. Murray BS, Choe SE, Woods M, Ryan TE, Liu W. An in silico analysis of microRNAs: mining the miRNAome. Mol Biosyst. 2010;6(10):1853-62.
3. Arora S, Rana R, Chhabra A, Jaiswal A, Rani V. miRNA-transcription factor interactions: A combinatorial regulation of gene expression. Mol Gen Genomics. 2013;288(3-4):77-87.
4. Gartel AL, Kandel ES. miRNAs: little known mediators of oncogenesis. Semin Cancer Biol. 2008;18(2):103-10.
5. Nam S, Li M, Choi K, Balch C, Kim S, Nephew KP. MicroRNA and mRNA integrated analysis (MMIA): A web tool for examining biological functions of microRNA expression. Nucleic Acids Res. 2009;37(Web Server issue): W356-62.
6. Macfarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Curr Genomics. 2010;11(7):537-61.
7. Lin SL, Miller JD, Ying SY. Intronic microRNA (miRNA). J Biomed Biotechnol. 2006;2006(4):26818.
8. Nazarov PV, Reinsbach SE, Muller A, Nicot N, Philippidou D, Vallar L, et al. Interplay of microRNAs, transcription factors and target genes: linking dynamic expression changes to function. Nucleic Acids Res. 2013;41(5): 2817-31.
9. Li L, Pan X, Li Z, Bai P, Jin H, Wang T, et al. Association between polymorphisms in the promoter region of miR-143/145 and risk of colorectal cancer. Hum Immunol. 2013;74(8):993-7.
10. Zhao Y, Du Y, Zhao S, Guo Z. Single-nucleotide polymorphisms of microRNA processing machinery genes and risk of colorectal cancer. Onco Targets Ther. 2015;8:421-5.
11. Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509-24.
12. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009; 11(3):228-34.
13. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597-610.
14. Agranat-Tamir L, Shomron N, Sperling J, Sperling R. Interplay between premRNA splicing and microRNA biogenesis within the supraspliceosome. Nucleic Acids Res. 2014;42(7):4640-51.
15. Saini HK, Griffiths-Jones S, Enright AJ. Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci U S A. 2007;104(45):17719-24.
16. Auyeung VC, Ulitsky I, McGeary SE, Bartel DP. Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing. Cell. 2013;152(4):844-58.
17. Westholm JO, Lai EC. Mirtrons: microRNA biogenesis via splicing. Biochimie. 2011;93(11):1897-904.
18. Tang X, Li M, Tucker L, Ramratnam B. Glycogen Synthase Kinase 3 Beta (GSK3beta) phosphorylates the RNAase III enzyme Drosha at S300 and S302. PLoS One. 2011;6(6):e20391.
19. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature. 2004;432(7014): 231-5.
20. Luciano DJ, Mirsky H, Vendetti NJ, Maas S. RNA editing of a miRNA precursor. RNA. 2004;10(8):1174-7.
21. Hibio N, Hino K, Shimizu E, Nagata Y, Ui-Tei K. Stability of miRNA 5terminal and seed regions is correlated with experimentally observed miRNAmediated silencing efficacy. Sci Rep. 2012;2:996.
22. Kai ZS, Pasquinelli AE. MicroRNA assassins: factors that regulate the disappearance of miRNAs. Nat Struct Mol Biol. 2010;17(1):5-10.
23. Sun G, Yan J, Noltner K, Feng J, Li H, Sarkis DA, et al. SNPs in human miRNA genes affect biogenesis and function. RNA. 2009;15(9):1640-51.
24. Stefani G, Chen X, Zhao H, Slack FJ. A novel mechanism of LIN-28 regulation of let-7 microRNA expression revealed by in vivo HITS-CLIP in C. elegans. RNA. 2015;21(5):985-96.
25. Heo I, Joo C, Kim YK, Ha M, Yoon MJ, Cho J, et al. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell. 2009;138(4):696-708.
26. Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, et al. Energy balance and colon cancer-beyond physical activity. Cancer Res. 1997;57(1): 75-80.
27. Slattery ML, Herrick JS, Mullany LE, Valeri N, Stevens J, Caan BJ, et al. An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int J Cancer. 2015;137(2):428-38.
28. Slattery ML, Herrick JS, Pellatt DF, Stevens JR, Mullany LE, Wolff E, et al. MicroRNA profiles in colorectal carcinomas, adenomas, and normal colonic mucosa: variations in miRNA expression and disease progression. Carcinogenesis. 2016;37:245-61.
29. Pellatt DF, Stevens JR, Wolff RK, Mullany LE, Herrick JS, Samowitz W, et al. Expression profiles of miRNA subsets distinguish human colorectal carcinoma and normal colonic mucosa. Clin Transl Gastroenterol. 2016;7: e152.
30. Suyundikov A, Stevens JR, Corcoran C, Herrick J, Wolff RK, Slattery ML. Accounting for dependence induced by weighted KNN imputation in paired samples, motivated by a colorectal cancer study. PLoS One. 2015; 10(4):e0119876.
31. Agilent Technologies I. Agilent GeneSpring user manual. Santa Clara: Aglient Technologies Inc; 2013 [cited 2015 July 16].
32. Slattery ML, Pellatt DF, Mullany LE, Wolff RK, Herrick JS. Gene expression in colon cancer: A focus on tumor site and molecular phenotype. Genes Chromosomes Cancer. 2015;54(9):527-41.
33. Buas MF, Onstad L, Levine DM, Risch HA, Chow WH, Liu G, et al. MiRNARelated SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium. PLoS One. 2015;10(6):e0128617.
34. Volk N, Shomron N. Versatility of MicroRNA biogenesis. PLoS One. 2011;6(5): e19391.
35. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res. 2001; 29(1):308-11.
36. Cunningham F, Amode MR, Barrell D, Beal K, Billis K, Brent S, et al. Ensembl 2015. Nucleic Acids Res. 2015;43(Database issue):D662-9.
37. Dunlop MG, Dobbins SE, Farrington SM, Jones AM, Palles C, Whiffin N, et al. Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat Genet. 2012;44(7):770-6.
38. Laurie CC, Doheny KF, Mirel DB, Pugh EW, Bierut LJ, Bhangale T, et al. Quality control and quality assurance in genotypic data for genome-wide association studies. Genet Epidemiol. 2010;34(6):591-602.
39. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6(2):65-70.
40. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet. 2004;74(4):765-9.
41. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity. 2005;95(3):221-7.
42. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc. 1995;57(1):289-300.
43. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9): 5116-21.
44. Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, et al. The UCSC table browser data retrieval tool. Nucleic Acids Res. 2004; 32(Database issue):D493-6.
45. Slattery ML, Lundgreen A, Wolff RK, Herrick JS, Caan BJ. Genetic variation in the transforming growth factor-beta-signaling pathway, lifestyle factors, and risk of colon or rectal cancer. Dis Colon Rectum. 2012;55(5):532-40.
46. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors. 2004;22(4):233-41.
47. NCBI. MAPKAPK2 mitogen-activated protein kinase-activated protein kinase 2 [ Homo sapiens (human) ]. NCBI Gene website. http://www. ncbi. nlm. nih. gov/gene/9261. April 20, 2016.
48. Chou CH, Chang NW, Shrestha S, Hsu SD, Lin YL, Lee WH, et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res. 2015;44:D239-47.